The estimated Net Worth of Vijay Tammara is at least $2.84 Thousand dollars as of 4 May 2021. Mr. Tammara owns over 15,711 units of Ocugen Inc stock worth over $2,843 and over the last 5 years he sold OCGN stock worth over $0. In addition, he makes $0 as Senior Vice President - Regulatory and Quality at Ocugen Inc.
Sign up
Mr. Tammara OCGN stock SEC Form 4 insiders trading
Vijay has made over 2 trades of the Ocugen Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 15,711 units of OCGN stock worth $12,726 on 4 May 2021.
The largest trade he's ever made was exercising 34,308 units of Ocugen Inc stock on 29 April 2021 worth over $24,359. On average, Vijay trades about 8,337 units every 1 days since 2020. As of 4 May 2021 he still owns at least 2,311 units of Ocugen Inc stock.
You can see the complete history of Mr. Tammara stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Vijay Tammara biography
Vijay Tammara Ph.D. serves as Senior Vice President - Regulatory and Quality of the Company. He has served as our Senior Vice President, Regulatory & Quality since December 2019 and previously served as our Vice President, Regulatory & Quality from September 2019 to December 2019. Dr. Tammara has served as Vice President, Regulatory & Quality of OpCo, our wholly owned subsidiary, since August 2017. Prior to joining OpCo, Dr. Tammara worked at VRT Pharma Consulting LLC, a business consulting company, as CEO and President from July 2014 to August 2017. Dr. Tammara previously served as VP Regulatory Affairs at Nuron Biotech Inc. from September 2010 to August 2013, Director of Regulatory Affairs at Merck & Co., Inc. from March 2004 to September 2010, Senior Associate Director at Wyeth Pharmaceuticals from September 2002 to March 2004, and Assistant Director at Sanofi-Synthelabo in Worldwide Regulatory Affairs from March 2000 to September 2000. Dr. Tammara received his Bachelor of Pharmacy from Kakatiya University, Master’s in Pharmacy from Nagpur University, and Ph.D. in Pharmaceutics from the University of Louisiana, Monroe, LA.
How old is Vijay Tammara?
Vijay Tammara is 60, he's been the Senior Vice President - Regulatory and Quality of Ocugen Inc since 2019. There are 4 older and 12 younger executives at Ocugen Inc. The oldest executive at Ocugen Inc is Prabhavathi Fernandes, 71, who is the Independent Director.
What's Vijay Tammara's mailing address?
Vijay's mailing address filed with the SEC is C/O OCUGEN, INC., 263 GREAT VALLEY PARKWAY, MALVERN, PA, 19355.
Insiders trading at Ocugen Inc
Over the last 5 years, insiders at Ocugen Inc have traded over $18,069,176 worth of Ocugen Inc stock and bought 1,511,356 units worth $684,830 . The most active insiders traders include Shankar Musunuri, Junge Zhang, and Uday Kompella. On average, Ocugen Inc executives and independent directors trade stock every 21 days with the average trade being worth of $96,347. The most recent stock trade was executed by Junge Zhang on 14 June 2023, trading 200,278 units of OCGN stock currently worth $100,139.
What does Ocugen Inc do?
ocugen, inc., is a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular disorders. the company’s lead programs in ocular graft versus host disease (ocu300) and chronic dry eye disease (ocu310) are expected to enter pivotal clinical trials in 2018. ocu300 received the first and only orphan drug designation for ocular graft versus host disease, providing certain regulatory and economic benefits. ocugen is also developing novel biologic therapies for retinitis pigmentosa (ocu100) and wet amd (ocu200), as well as a groundbreaking modifier gene therapy platform with potential to address a broad spectrum of inherited retinal disorders (ocu400). for more information, please visit www.ocugen.com.
What does Ocugen Inc's logo look like?
Complete history of Mr. Tammara stock trades at Ocugen Inc
Ocugen Inc executives and stock owners
Ocugen Inc executives and other stock owners filed with the SEC include:
-
Dr. Shankar Musunuri M.B.A., MBA, Ph.D.,
Co-Founder, Chairman & CEO -
Shankar Musunuri,
Chairman of the Board, Chief Executive Officer -
Sanjay S. Subramanian M.B.A.,
Chief Accounting Officer, CFO, Treasurer, Head of Corp. Devel. & Corp. Sec. -
Rasappa Arumugham,
Chief Scientific Officer -
Dr. Uday B. Kompella Ph.D.,
Co-founder & Independent Director -
Junge Zhang,
Independent Director -
Suha Taspolatoglu,
Independent Director -
Manish Potti,
Independent Director -
Ramesh Kumar,
Independent Director -
Uday Kompella,
Independent Director -
Prabhavathi Fernandes,
Independent Director -
Kirsten Castillo,
Independent Director -
Kelly Beck,
Vice President, Investor Relations and Administration and Corporate Secretary -
Vijay Tammara,
Senior Vice President - Regulatory and Quality -
Sanjay Subramanian,
Chief Financial Officer, Chief Accounting Officer, Treasurer -
Michael Shine,
Sr. VP of Commercial -
J. P. Gabriel,
Sr. VP of Manufacturing & Supply Chain -
Dr. Bruce D. Forrest B.S., M.B.A., M.D.,
Acting Chief Medical Officer & Vaccine Scientific Advisory Board Member -
Dr. Arun Upadhyay Ph.D.,
Head of Research, Devel. & Discovery -
Dr. Vijay Tammara,
Sr. VP of Regulatory & Quality -
Zara Gaudioso,
Head of HR -
Ken Inchausti,
Head of Investor Relations & Communications -
Jessica Crespo,
CAO/SVP, Finance -
Daniel Jorgensen,
Chief Medical Officer -
Frank Leo,
Director -
Marna C Whittington,
Director -
Huma Qamar,
Chief Medical Officer -
Arun Upadhyay,
See Remarks